485 related articles for article (PubMed ID: 29082918)
1. The unique structural and functional features of CXCL12.
Janssens R; Struyf S; Proost P
Cell Mol Immunol; 2018 Apr; 15(4):299-311. PubMed ID: 29082918
[TBL] [Abstract][Full Text] [Related]
2. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
3. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
4. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.
Cambier S; Gouwy M; Proost P
Cell Mol Immunol; 2023 Mar; 20(3):217-251. PubMed ID: 36725964
[TBL] [Abstract][Full Text] [Related]
5. Pathological roles of the homeostatic chemokine CXCL12.
Janssens R; Struyf S; Proost P
Cytokine Growth Factor Rev; 2018 Dec; 44():51-68. PubMed ID: 30396776
[TBL] [Abstract][Full Text] [Related]
6. Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.
Janssens R; Mortier A; Boff D; Vanheule V; Gouwy M; Franck C; Larsen O; Rosenkilde MM; Van Damme J; Amaral FA; Teixeira MM; Struyf S; Proost P
Oncotarget; 2016 Sep; 7(38):62439-62459. PubMed ID: 27566567
[TBL] [Abstract][Full Text] [Related]
7. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J
Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140
[TBL] [Abstract][Full Text] [Related]
8. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
[TBL] [Abstract][Full Text] [Related]
9. Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation
Janssens R; Boff D; Ruytinx P; Mortier A; Vanheule V; Larsen O; Daugvilaite V; Rosenkilde MM; Noppen S; Liekens S; Schols D; De Meester I; Opdenakker G; Struyf S; Teixeira MM; Amaral FA; Proost P
Front Immunol; 2018; 9():1933. PubMed ID: 30233568
[TBL] [Abstract][Full Text] [Related]
10. The good and bad faces of the CXCR4 chemokine receptor.
Teixidó J; Martínez-Moreno M; Díaz-Martínez M; Sevilla-Movilla S
Int J Biochem Cell Biol; 2018 Feb; 95():121-131. PubMed ID: 29288743
[TBL] [Abstract][Full Text] [Related]
11. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
12. The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4.
Laguri C; Sadir R; Rueda P; Baleux F; Gans P; Arenzana-Seisdedos F; Lortat-Jacob H
PLoS One; 2007 Oct; 2(10):e1110. PubMed ID: 17971873
[TBL] [Abstract][Full Text] [Related]
13. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.
Ziarek JJ; Veldkamp CT; Zhang F; Murray NJ; Kartz GA; Liang X; Su J; Baker JE; Linhardt RJ; Volkman BF
J Biol Chem; 2013 Jan; 288(1):737-46. PubMed ID: 23148226
[TBL] [Abstract][Full Text] [Related]
14. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
Hara T; Tanegashima K
Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
[TBL] [Abstract][Full Text] [Related]
15. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases.
García-Cuesta EM; Santiago CA; Vallejo-Díaz J; Juarranz Y; Rodríguez-Frade JM; Mellado M
Front Endocrinol (Lausanne); 2019; 10():585. PubMed ID: 31507535
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
[TBL] [Abstract][Full Text] [Related]
17. The N-terminus of CXCR4 splice variants determines expression and functional properties.
Park HK; Nguyen LP; Nguyen TU; Cho M; Nguyen HT; Hurh S; Kim HR; Seong JY; Lee CS; Ham BJ; Hwang JI
PLoS One; 2023; 18(5):e0283015. PubMed ID: 37141381
[TBL] [Abstract][Full Text] [Related]
18. A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities.
Altenburg JD; Broxmeyer HE; Jin Q; Cooper S; Basu S; Alkhatib G
J Virol; 2007 Aug; 81(15):8140-8. PubMed ID: 17507482
[TBL] [Abstract][Full Text] [Related]
19. The dimeric form of CXCL12 binds to atypical chemokine receptor 1.
Gutjahr JC; Crawford KS; Jensen DR; Naik P; Peterson FC; Samson GPB; Legler DF; Duchene J; Veldkamp CT; Rot A; Volkman BF
Sci Signal; 2021 Aug; 14(696):. PubMed ID: 34404752
[TBL] [Abstract][Full Text] [Related]
20. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
